Medidata NEXT
The Premier Clinical Trials Conference Series
Connect with the industry’s best.
Medidata NEXT is your chance to network with peers, learn from leading organizations, and discover solutions to life sciences’ biggest challenges.

Why Attend Medidata NEXT?
Medidata NEXT is more than a clinical trials conference—it’s an experience built to captivate the greatest life sciences minds. Don’t miss your chance to join hundreds of leaders across pharma, biotech, medtech, CROs, and research sites who are responsible for addressing key issues in digital health.
- Learn from the world’s experts as we explore the latest advancements.
- Network with colleagues and peers who have faced similar challenges.
- Discover Medidata’s latest innovations and product roadmap.
Registration is free for our customers and qualified members of the life sciences community.
NEXT by the Numbers
Attendees
Companies
Sessions
Cities

The Medidata NEXT City Series
The next step in the growth of our signature event is a global reimagining. The NEXT City Series brings the premier clinical trials conference experience to customers around the world.
We’re taking NEXT on the road across numerous countries and cities. From metropolitan hubs to sunny shores, you don’t want to miss this immersive industry event.
Click on the city you’re interested in below to learn more and register.
Testimonials

“What I love is walking the exhibit floor and seeing the different tools that Medidata and partners have incorporated. I also love the sessions. The combination of looking at what the product is and hearing some of the trends in the industry really make it a valuable day.”
– Bunny Ellerin, Co-founder & CEO, Digital Health New York

“It’s been brilliant. I’ve learned what developments the company’s working on, and some of them are quite amazing, especially integration of the AI and machine learning into the system, which will allow you to analyze the data on an ongoing basis and propose solutions on the spot.”
– Dilshat Djumanov, Director of Data Science, Richmond Pharmacology (CRO)